Filing Flows

Filing Flows › Oscar Health (OSCR) › Guidance & outlook

Oscar Health (OSCR) guidance and outlook

Oscar Health's 10-Q filed Nov 5, 2026 makes 13 forward-looking statements.

Guidance and outlook

Oscar Health: what its forward-looking statements are about (10-Q filed 2026-11-05)Oscar Health: what its forward-looking statements are about (10-Q filed 2026-11-05)Other9Legal & regulation1Demand1Margins1Financing1
13 statements; tone -0.15 (−1 all cautious, +1 all confident); 4 hedged.
Oscar Health: outlook statements against the filing beforeOscar Health: outlook statements against the filing beforeConfident1Cautious3

Forward-looking statements, 10-Q filed Nov 5, 2026

Oscar Health's latest quarter

Oscar Health, Q3 2026: revenue $5.1B (+72% year over year), operating margin 3.5%, net earnings $167M, operating cash flow −$1.2B. The chart follows the revenue to costs, profit and cash.

Questions

What does Oscar Health expect?

The following regulatory developments have impacted our operations during the periods presented in the financial statements contained elsewhere in this Quarterly Report on Form 10-Q, or are expected to impact our results of operations in future periods. • The current presidential administration and the Centers for Medicare & Medicaid Services (“CMS”) are increasingly focused on improving integrity in the Health Insurance Marketplaces’ eligibility and enrollment process, and we expect this focus to continue. If the Stayed Provisions are implemented, we expect these provisions to impact APTC eli

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.